People

Enlyton’s strengths:

• extensive oncology experience

• tumor imaging

• intraoperative cancer detection

• Phase I-III clinical trials

• radiolabeled antibody development and associated pharmacokinetics

• design and development of detection methods and associated instrumentation

• corporate partnering and commercialization